serine/threonine kinase 32B | YANK family | IUPHAR/BPS Guide to PHARMACOLOGY

Top ▲

serine/threonine kinase 32B

Target not currently curated in GtoImmuPdb

Target id: 1538

Nomenclature: serine/threonine kinase 32B

Abbreviated Name: YANK2

Family: YANK family

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 414 4p16 STK32B serine/threonine kinase 32B
Mouse - 414 5 B2 Stk32b serine/threonine kinase 32B
Rat - 414 14q21 Stk32b serine/threonine kinase 32B
Previous and Unofficial Names
Database Links
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
RefSeq Nucleotide
RefSeq Protein
Enzyme Reaction
EC Number:

Download all structure-activity data for this target as a CSV file

Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
compound 74 [PMID: 24793884] Hs Inhibition - - 2
Description: Measured as % inhibition using 1μM compound.
Inhibitor Comments
STK32B activity is completely abolished in the presence of 1μM compound 74 [PMID 24793884] [2] (note that STK32B is referred to by its synonym YANK2 in the article's Supplementary data table)..
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
Reference: 1,3

Key to terms and symbols Click column headers to sort
Target used in screen: YANK2
Ligand Sp. Type Action Value Parameter
NVP-TAE684 Hs Inhibitor Inhibition 7.6 pKd
staurosporine Hs Inhibitor Inhibition 7.0 pKd
linifanib Hs Inhibitor Inhibition 6.6 pKd
PD-173955 Hs Inhibitor Inhibition 5.9 pKd
PP-242 Hs Inhibitor Inhibition 5.8 pKd
SB203580 Hs Inhibitor Inhibition 5.7 pKd
ruboxistaurin Hs Inhibitor Inhibition <5.5 pKd
erlotinib Hs Inhibitor Inhibition <5.5 pKd
GSK690693 Hs Inhibitor Inhibition <5.5 pKd
masitinib Hs Inhibitor Inhibition <5.5 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »


Show »

1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

2. Reichelt A, Bailis JM, Bartberger MD, Yao G, Shu H, Kaller MR, Allen JG, Weidner MF, Keegan KS, Dao JH. (2014) Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors. Eur J Med Chem, 80: 364-82. [PMID:24793884]

3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

How to cite this page

YANK family: serine/threonine kinase 32B. Last modified on 25/02/2015. Accessed on 15/08/2020. IUPHAR/BPS Guide to PHARMACOLOGY,